GBD 2017 Cirrhosis Collaborators (2020) The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 5:245–266
Farges O, Malassagne B, Flejou JF et al (1999) Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 229:210–215
Article CAS PubMed PubMed Central Google Scholar
Midorikawa Y, Kubota K, Takayama T et al (1999) A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery 126:484–491
Article CAS PubMed Google Scholar
Cadranel JF, Rufat P, Degos F (2000) Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the study of the liver (AFEF). Hepatology (Baltimore MD) 32:477–481
Article CAS PubMed Google Scholar
Sporea I, Popescu A, Sirli R (2008) Why, who and how should perform liver biopsy in chronic liver diseases. World J Gastroenterol 14:3396–3402
Article PubMed PubMed Central Google Scholar
Regev A, Berho M, Jeffers LJ et al (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97:2614–2618
Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP (2006) An appraisal of the histopathological assessment of liver fibrosis. Gut 55:569–578
Article CAS PubMed PubMed Central Google Scholar
Vallet-Pichard A, Mallet V, Nalpas B et al (2007) FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology (Baltimore MD) 46:32–36
Article CAS PubMed Google Scholar
Ding Y, Wang Z, Niu H et al (2023) FIB-4 is closer to FibroScan screen results to detecting advanced liver fibrosis and maybe facilitates NAFLD warning. Med (Baltim) 102:e34957
Makuuchi M, Kokudo N, Arii S et al (2008) Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 38:37–51
European Association for the Study of the Liver (2021) EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update. J Hepatol 75:659–689
Karlsen TH, Sheron N, Zelber-Sagi S et al (2022) The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality. Lancet 399:61–116
Graupera I, Thiele M, Serra-Burriel M et al (2022) Low accuracy of FIB-4 and NAFLD Fibrosis scores for Screening for Liver Fibrosis in the Population. Clin Gastroenterol Hepatol 20:2567–2576e2566
Article CAS PubMed Google Scholar
Hagström H, Talbäck M, Andreasson A, Walldius G, Hammar N (2020) Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease. J Hepatol 73:1023–1029
Hanaki T, Uchinaka EI, Yagyu T et al (2020) A Novel Noninvasive Method for Predicting Liver Fibrosis by Quantifying the Estrangement of Indocyanine Green Retention Rate and Tc-99m-diethylenetriamine-penta-acetic Acid-galactosyl Human Serum Albumin Scintigraphy. In Vivo 34:1187–1193
Article CAS PubMed PubMed Central Google Scholar
Kudo M, Washino K, Yamamichi Y, Ikekubo K (1994) Synthesis and radiolabeling of galactosyl human serum albumin. Methods Enzymol 247:383–394
Article CAS PubMed Google Scholar
Beppu T, Hayashi H, Okabe H et al (2011) Liver functional volumetry for portal vein embolization using a newly developed 99mTc-galactosyl human serum albumin scintigraphy SPECT-computed tomography fusion system. J Gastroenterol 46:938–943
Iimuro Y, Kashiwagi T, Yamanaka J et al (2010) Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters. J Hepatobiliary Pancreat Sci 17:673–681
Sumiyoshi T, Shima Y, Okabayashi T et al (2014) Functional discrepancy between two liver lobes after hemilobe biliary drainage in patients with jaundice and bile duct cancer: an appraisal using 99mTc-GSA SPECT/CT fusion imaging. Radiology 273:444–451
Okabe H, Beppu T, Hayashi H et al (2014) Rank classification based on the combination of indocyanine green retention rate at 15 min and 99mTc-DTPA-galactosyl human serum albumin scintigraphy predicts the safety of hepatic resection. Nucl Med Commun 35:478–483
Article CAS PubMed Google Scholar
Huang X, Chen Y, Shao M et al (2020) The value of 99mTc-labeled galactosyl human serum albumin single-photon emission computerized tomography/computed tomography on regional liver function assessment and posthepatectomy failure prediction in patients with hilar cholangiocarcinoma. Nucl Med Commun 41:1128–1135
Article CAS PubMed Google Scholar
Kato A, Nakamoto Y, Ishimori T et al (2018) Predictability of 99mTc-Galactosyl Human serum albumin scintigraphy for Posthepatectomy Liver failure. AJR Am J Roentgenol 210:158–165
Sumiyoshi T, Okabayashi T, Negoro Y et al (2018) 99mTc-GSA SPECT/CT fusion imaging for hepatectomy candidates with extremely deteriorated ICG value. Jpn J Radiol 36:537–543
Tokorodani R, Kume T, Daisaki H et al (2023) Combining 99mTc-GSA single-photon emission-computed tomography and Gd-EOB-DTPA-enhanced magnetic resonance imaging for staging liver fibrosis. Med (Baltim) 102:e32975
Wu J, Ishikawa N, Takeda T et al (1995) The functional hepatic volume assessed by 99mTc-GSA hepatic scintigraphy. Ann Nucl Med 9:229–235
Article CAS PubMed Google Scholar
Ludwig J (1993) The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 105:274–278
Article CAS PubMed Google Scholar
Tomita K, Chiba N, Ochiai S et al (2021) Prognostic value of future liver remnant LU15 index of 99mTc-galactosyl serum albumin scintigraphy for predicting posthepatectomy liver failure. PLoS ONE 16:e0247675
Article CAS PubMed PubMed Central Google Scholar
Yamazaki K, Nishii R, Mizutani Y et al (2023) Estimation of post-therapeutic liver reserve capacity using 99mTc-GSA scintigraphy prior to carbon-ion radiotherapy for liver tumors. Eur J Nucl Med Mol Imaging 50:581–592
Article CAS PubMed Google Scholar
Schroeder RA, Marroquin CE, Bute BP et al (2006) Predictive indices of morbidity and mortality after liver resection. Ann Surg 243:373–379
Article PubMed PubMed Central Google Scholar
Torizuka K, Ha-Kawa SK, Ikekubo K et al (1991) Phase I clinical study on 99mTc-GSA, a new agent for functional imaging of the liver. Kaku Igaku 28:1321–1331
Comments (0)